Top

Current Hypertension Reports

Published in:

01-12-2018 | Blood Pressure Monitoring and Management (J Cockcroft, Section Editor)

Out of Office Blood Pressure Measurement in Pregnancy and the Postpartum Period

Authors: Natalie A. Bello, Eliza Miller, Kirsten Cleary, Ronald Wapner, Daichi Shimbo, Alan T. Tita

Published in: Current Hypertension Reports | Issue 12/2018

Abstract

Purpose

Hypertensive disorders of pregnancy are increasing in prevalence and associated with significant maternal and perinatal morbidity and mortality.

Recent Findings

Increased emphasis has been placed recently on the use of out-of-office (i.e., home and ambulatory) blood pressure (BP) monitoring to diagnose and manage hypertension in the general population. Current guidelines offer limited recommendations on the use of out-of-office BP monitoring during pregnancy and postpartum.

Summary

This review will discuss the recent literature on BP measurement outside of the office and its use for screening, diagnosis, and treatment in pregnancy and postpartum, and will illuminate areas for future research.

•• Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstetrics and gynecology. 2013;122(5):1122–31. doi:https://doi.org/10.1097/01.aog.0000437382.03963.88.

Berg CJ, Mackay AP, Qin C, Callaghan WM. Overview of maternal morbidity during hospitalization for labor and delivery in the United States: 1993-1997 and 2001-2005. Obstet Gynecol. 2009;113(5):1075–81. https://doi.org/10.1097/AOG.0b013e3181a09fc0.CrossRefPubMed

Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017;40(3):213–20. https://doi.org/10.1038/hr.2016.126.CrossRefPubMed

• Sutton ALM, Harper LM, Tita ATN. Hypertensive disorders in pregnancy. Obstet Gynecol Clin N Am. 2018;45(2):333–47. https://doi.org/10.1016/j.ogc.2018.01.012.CrossRef

Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol. 2009;113(6):1299–306. https://doi.org/10.1097/AOG.0b013e3181a45b25.CrossRefPubMed

Callaghan WM, Creanga AA, Kuklina EV. Severe maternal morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol. 2012;120(5):1029–36. https://doi.org/10.1097/AOG.0b013e31826d60c5.CrossRefPubMed

Leffert LR, Clancy CR, Bateman BT, Bryant AS, Kuklina EV. Hypertensive disorders and pregnancy-related stroke: frequency, trends, risk factors, and outcomes. Obstet Gynecol. 2015;125(1):124–31. https://doi.org/10.1097/aog.0000000000000590.CrossRefPubMedPubMedCentral

Roberts JM, Pearson GD, Cutler JA, Lindheimer MD. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension in pregnancy. 2003;22(2):109–27. https://doi.org/10.1081/prg-120016792.CrossRefPubMed

Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol. 2015;125(1):5–12. https://doi.org/10.1097/aog.0000000000000564.CrossRefPubMed

10.

• Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–33. https://doi.org/10.1016/s2214-109x(14)70227-x.CrossRefPubMed

11.

• Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372(5):407–17. https://doi.org/10.1056/NEJMoa1404595.CrossRefPubMed

12.

Garovic VD, August P. Preeclampsia and the future risk of hypertension: the pregnant evidence. Curr Hypertens Rep. 2013;15(2):114–21. https://doi.org/10.1007/s11906-013-0329-4.CrossRefPubMed

13.

•• Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcome. 2017;10(2). doi:https://doi.org/10.1161/circoutcomes.116.003497.

14.

Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol. 2011;57(12):1404–23. https://doi.org/10.1016/j.jacc.2011.02.005.CrossRefPubMedPubMedCentral

15.

•• Dunietz GL, Strutz KL, Holzman C, Tian Y, Todem D, Bullen BL, et al. Moderately elevated blood pressure during pregnancy and odds of hypertension later in life: the POUCHmoms longitudinal study. BJOG: Int J Obstet Gynaecol. 2017;124:1606–13. https://doi.org/10.1111/1471-0528.14556.CrossRef

16.

Mannisto T, Mendola P, Vaarasmaki M, Jarvelin MR, Hartikainen AL, Pouta A, et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation. 2013;127(6):681–90. https://doi.org/10.1161/circulationaha.112.128751.CrossRefPubMedPubMedCentral

17.

Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension (Dallas, Tex : 1979). 2009;53(6):944–51. https://doi.org/10.1161/hypertensionaha.109.130765.CrossRef

18.

•• Tooher J, Thornton C, Makris A, Ogle R, Korda A, Hennessy A. All hypertensive disorders of pregnancy increase the risk of future cardiovascular disease. Hypertension (Dallas, Tex : 1979). 2017;70(4):798–803. https://doi.org/10.1161/hypertensionaha.117.09246.CrossRef

19.

• Goel A, Maski MR, Bajracharya S, Wenger JB, Zhang D, Salahuddin S, et al. Epidemiology and mechanisms of de novo and persistent hypertension in the postpartum period. Circulation. 2015;132(18):1726–33. https://doi.org/10.1161/circulationaha.115.015721.CrossRefPubMedPubMedCentral

20.

Walters BN, Thompson ME, Lee A, de Swiet M. Blood pressure in the puerperium. Clin Sci (London, England : 1979). 1986;71(5):589–94.CrossRef

21.

Walters BN, Walters T. Hypertension in the puerperium. Lancet (London, England). 1987;2(8554):330.CrossRef

22.

Clapp MA, Little SE, Zheng J, Robinson JN. A multi-state analysis of postpartum readmissions in the United States. Am J Obstet Gynecol. 2016;215(1):113.e1–e10. https://doi.org/10.1016/j.ajog.2016.01.174.CrossRef

23.

•• Nathan HL, Duhig K, Hezelgrave NL, Chappell LC, Shennan AH. Blood pressure measurement in pregnancy. Obstet Gynaecol. 2015;17(2):91–8. https://doi.org/10.1111/tog.12173.CrossRef

24.

Shennan AH, Halligan AW. Measuring blood pressure in normal and hypertensive pregnancy. Best Pract Res Clin Obstet Gynaecol. 1999;13(1):1–26.CrossRef

25.

ACOG Practice Bulletin. Chronic hypertension in pregnancy. ACOG committee on practice bulletins. Obstet Gynecol. 2001;98(1):suppl 177–185.

26.

Sibai BM, Lindheimer M, Hauth J, Caritis S, VanDorsten P, Klebanoff M, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development network of maternal-fetal medicine units. N Engl J Med. 1998;339(10):667–71. https://doi.org/10.1056/nejm199809033391004.CrossRefPubMed

27.

Meis PJ, Goldenberg RL, Mercer BM, Iams JD, Moawad AH, Miodovnik M, et al. The preterm prediction study: risk factors for indicated preterm births. Maternal-fetal medicine units network of the National Institute of Child Health and Human Development. Am J Obstet Gynecol. 1998;178(3):562–7.CrossRef

28.

Harper LM, Biggio JR, Anderson S, Tita AT. Gestational age of delivery in pregnancies complicated by chronic hypertension. Obstet Gynecol. 2016;127(6):1101–9. https://doi.org/10.1097/aog.0000000000001435.CrossRefPubMedPubMedCentral

29.

James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (jnc 8). JAMA. 2014;311(5):507–20. https://doi.org/10.1001/jama.2013.284427.CrossRef

30.

Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension (Dallas, Tex : 1979). 2005;45(1):142–61.CrossRef

31.

Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354(22):2368–74. https://doi.org/10.1056/NEJMra060433.CrossRefPubMed

32.

Shimbo D, Abdalla M, Falzon L, Townsend RR, Muntner P. Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic review. J Am Soc Hypertens: JASH. 2015;10:224–234.e17. https://doi.org/10.1016/j.jash.2015.12.013.CrossRefPubMed

33.

•• Stergiou GS, Dolan E, Kollias A, Poulter NR, Shennan A, Staessen JA, et al. Blood pressure measurement in special populations and circumstances. J Clin Hypertens. 2018;20(7):1122–7. https://doi.org/10.1111/jch.13296.CrossRef

34.

O'Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R, et al. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit. 2010;15(1):23–38. https://doi.org/10.1097/MBP.0b013e3283360e98.CrossRefPubMed

35.

O'Brien E, Petrie J, Littler W, de Swiet M, Padfield PL, Altman DG, et al. An outline of the revised British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens. 1993;11(6):677–9.CrossRef

36.

Non-invasive sphygmomanometers - part 2: clinical investigation of automated measurement type. American National Standards Institute. ANSI/AAMI/ISO 81060-2;2013. http://webstore.ansi.org.

37.

•• Stergiou GS, Alpert B, Mieke S, Asmar R, Atkins N, Eckert S, et al. A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) collaboration statement. Hypertension (Dallas, Tex : 1979). 2018;71(3):368–74. https://doi.org/10.1161/hypertensionaha.117.10237.CrossRef

38.

•• Bello NA, Woolley JJ, Cleary KL, Falzon L, Alpert BS, Oparil S, et al. Accuracy of blood pressure measurement devices in pregnancy: a systematic review of validation studies. Hypertension (Dallas, Tex : 1979). 2017. https://doi.org/10.1161/hypertensionaha.117.10295.CrossRef

39.

Hodgkinson JA, Sheppard JP, Heneghan C, Martin U, Mant J, Roberts N, et al. Accuracy of ambulatory blood pressure monitors: a systematic review of validation studies. J Hypertens. 2013;31(2):239–50. https://doi.org/10.1097/HJH.0b013e32835b8d8b.CrossRefPubMed

40.

U.S. Preventive Services Task Force. Screening for preeclampsia: US preventive services task force recommendation statement. JAMA. 2017;317(16):1661–7. https://doi.org/10.1001/jama.2017.3439.CrossRef

41.

Siu AL. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(10):778–86. https://doi.org/10.7326/m15-2223.CrossRefPubMed

42.

Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;71:e127–248. https://doi.org/10.1016/j.jacc.2017.11.006.CrossRefPubMed

43.

Tucker KL, Taylor KS, Crawford C, Hodgkinson JA, Bankhead C, Carver T, et al. Blood pressure self-monitoring in pregnancy: examining feasibility in a prospective cohort study. BMC Pregnancy Childbirth. 2017;17(1):442. https://doi.org/10.1186/s12884-017-1605-0.CrossRefPubMedPubMedCentral

44.

Naef RW 3rd, Perry KG Jr, Magann EF, McLaughlin BN, Chauhan SP, Morrison JC. Home blood pressure monitoring for pregnant patients with hypertension. J Perinatol. 1998;18(3):226–9.PubMed

45.

Lo C, Taylor RS, Gamble G, McCowan L, North RA. Use of automated home blood pressure monitoring in pregnancy: is it safe? Am J Obstet Gynecol. 2002;187(5):1321–8.CrossRef

46.

Brown MA, Robinson A, Bowyer L, Buddle ML, Martin A, Hargood JL, et al. Ambulatory blood pressure monitoring in pregnancy: what is normal? Am J Obstet Gynecol. 1998;178(4):836–42.CrossRef

47.

Dalton KJ, Manning K, Robarts PJ, Dripps JH, Currie JR. Computerized home telemetry of maternal blood pressure in hypertensive pregnancy. Int J Biomed Comput. 1987;21(3–4):175–87.CrossRef

48.

Eguchi K, Ohmaru T, Ohkuchi A, Hirashima C, Takahashi K, Suzuki H, et al. Ambulatory BP monitoring and clinic BP in predicting small-for-gestational-age infants during pregnancy. J Hum Hypertens. 2016;30(1):62–7. https://doi.org/10.1038/jhh.2015.20.CrossRefPubMed

49.

Metoki H, Ohkubo T, Obara T, Akutsu K, Yamamoto M, Ishikuro M, et al. Daily serial hemodynamic data during pregnancy and seasonal variation: the BOSHI study. Clin Exp Hypertens. 2012;34(4):290–6. https://doi.org/10.3109/10641963.2012.681086.CrossRefPubMed

50.

Rey E, Morin F, Boudreault J, Pilon F, Vincent D, Ouellet D. Blood pressure assessments in different subtypes of hypertensive pregnant women: office versus home patient- or nurse-measured blood pressure. Hypertens Pregnancy. 2009;28(2):168–77. https://doi.org/10.1080/10641950802233072.CrossRefPubMed

51.

Rey E, Pilon F, Boudreault J. Home blood pressure levels in pregnant women with chronic hypertension. Hypertens Pregnancy. 2007;26(4):403–14.CrossRef

52.

Ochsenbein-Kolble N, Roos M, Gasser T, Huch R, Huch A, Zimmermann R. Cross sectional study of automated blood pressure measurements throughout pregnancy. BJOG Int J Obstet Gynaecol. 2004;111(4):319–25.CrossRef

53.

Denolle T, Daniel JC, Calvez C, Ottavioli JN, Esnault V, Herpin D. Home blood pressure during normal pregnancy. Am J Hypertens. 2005;18(9 Pt 1):1178–80.CrossRef

54.

Mikami Y, Takai Y, Era S, Ono Y, Saitoh M, Baba K, et al. Provisional criteria for the diagnosis of hypertension in pregnancy using home blood pressure measurements. Hypertens Res. 2017;40(7):679–84. https://doi.org/10.1038/hr.2017.6.CrossRefPubMedPubMedCentral

55.

Peek M, Shennan A, Halligan A, Lambert PC, Taylor DJ, De Swiet M. Hypertension in pregnancy: which method of blood pressure measurement is most predictive of outcome? Obstet Gynecol. 1996;88(6):1030–3. https://doi.org/10.1016/s0029-7844(96)00350-x.CrossRefPubMed

56.

Denolle T, Weber JL, Calvez C, Getin Y, Daniel JC, Lurton O, et al. Diagnosis of white coat hypertension in pregnant women with teletransmitted home blood pressure. Hypertens Pregnancy. 2008;27(3):305–13. https://doi.org/10.1080/10641950802000950.CrossRefPubMed

57.

Bar J, Maymon R, Padoa A, Wittenberg C, Boner G, Ben-Rafael Z, et al. White coat hypertension and pregnancy outcome. J Hum Hypertens. 1999;13(8):541–5.CrossRef

58.

Bellomo G, Narducci PL, Rondoni F, Pastorelli G, Stangoni G, Angeli G, et al. Prognostic value of 24-hour blood pressure in pregnancy. JAMA. 1999;282(15):1447–52.CrossRef

59.

Brown MA, Robinson A, Jones M. The white coat effect in hypertensive pregnancy: much ado about nothing? Br J Obstet Gynaecol. 1999;106(5):474–80.CrossRef

60.

Reinders A, Cuckson AC, Lee JT, Shennan AH. An accurate automated blood pressure device for use in pregnancy and pre-eclampsia: the Microlife 3BTO-A. BJOG Int J Obstet Gynaecol. 2005;112(7):915–20.CrossRef

61.

de Greeff A, Beg Z, Gangji Z, Dorney E, Shennan AH. Accuracy of inflationary versus deflationary oscillometry in pregnancy and preeclampsia: OMRON-MIT versus OMRON-M7. Blood Press Monit. 2009;14(1):37–40. https://doi.org/10.1097/MBP.0b013e32831e305d.CrossRefPubMed

62.

Chung Y, de Greeff A, Shennan A. Validation and compliance of a home monitoring device in pregnancy: microlife WatchBP home. Hypertens Pregnancy. 2009;28(3):348–59. https://doi.org/10.1080/10641950802601286.CrossRefPubMed

63.

Shimbo D, Abdalla M, Falzon L, Townsend RR, Muntner P. Role of ambulatory and home blood pressure monitoring in clinical practice: a narrative review. Ann Intern Med. 2015;163(9):691–700. https://doi.org/10.7326/m15-1270.CrossRefPubMedPubMedCentral

64.

•• Salazar MR, Espeche WG, Leiva Sisnieguez BC, Balbin E, Leiva Sisnieguez CE, Stavile RN, et al. Significance of masked and nocturnal hypertension in normotensive women coursing a high-risk pregnancy. J Hypertens. 2016;34(11):2248–52. https://doi.org/10.1097/hjh.0000000000001067.CrossRefPubMed

65.

Hermida RC, Ayala DE. Prognostic value of office and ambulatory blood pressure measurements in pregnancy. Hypertension (Dallas, Tex : 1979). 2002;40(3):298–303.CrossRef

66.

Anstey DE, Pugliese D, Abdalla M, Bello NA, Givens R, Shimbo D. An update on masked hypertension. Curr Hypertens Rep. 2017;19(12):94. https://doi.org/10.1007/s11906-017-0792-4.CrossRefPubMedPubMedCentral

67.

Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol. 1990;162(4):960–6 discussion 6-7.CrossRef

68.

El Guindy AA, Nabhan AF. A randomized trial of tight vs. less tight control of mild essential and gestational hypertension in pregnancy. J Perinat Med. 2008;36(5):413–8. https://doi.org/10.1515/jpm.2008.060.CrossRefPubMed

69.

Fabregues G, Alvarez L, Varas Juri P, Drisaldi S, Cerrato C, Moschettoni C, et al. Effectiveness of atenolol in the treatment of hypertension during pregnancy. Hypertension (Dallas, Tex : 1979). 1992;19(2 Suppl):Ii129–31.

70.

Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension (Dallas, Tex : 1979). 2008;51(4):960–9. https://doi.org/10.1161/hypertensionaha.106.075895.CrossRef

71.

Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2014;2:Cd002252. https://doi.org/10.1002/14651858.CD002252.pub3.CrossRef

72.

Sibai BM. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol. 2012;206(6):470–5. https://doi.org/10.1016/j.ajog.2011.09.002.CrossRefPubMed

73.

Crovetto F, Somigliana E, Peguero A, Figueras F. Stroke during pregnancy and pre-eclampsia. Curr Opin Obstet Gynecol. 2013;25(6):425–32. https://doi.org/10.1097/gco.0000000000000024.CrossRefPubMed

74.

Hasegawa J, Ikeda T, Sekizawa A, Tanaka H, Nakata M, Murakoshi T, et al. Maternal death due to stroke associated with pregnancy-induced hypertension. Circulation Journal. 2015;79(8):1835–40. https://doi.org/10.1253/circj.CJ-15-0297.CrossRefPubMed

75.

Committee Opinion No ACOG. 736: optimizing postpartum care. Obstet Gynecol. 2018;131(5):e140–e50. https://doi.org/10.1097/aog.0000000000002633.CrossRef

76.

•• Ishikuro M, Obara T, Metoki H, Ohkubo T, Yamamoto M, Akutsu K, et al. Blood pressure measured in the clinic and at home during pregnancy among nulliparous and multiparous women: the BOSHI study. Am J Hypertens. 2013;26(1):141–8. https://doi.org/10.1093/ajh/hps002.CrossRefPubMed

Title: Out of Office Blood Pressure Measurement in Pregnancy and the Postpartum Period
Authors: Natalie A. Bello
Eliza Miller
Kirsten Cleary
Ronald Wapner
Daichi Shimbo
Alan T. Tita
Publication date: 01-12-2018
Publisher: Springer US
Published in: Current Hypertension Reports / Issue 12/2018
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI: https://doi.org/10.1007/s11906-018-0901-z

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Out of Office Blood Pressure Measurement in Pregnancy and the Postpartum Period

Abstract

Purpose

Recent Findings

Summary

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 12/2018

Inflammation as a Regulator of the Renin-Angiotensin System and Blood Pressure

Inflammation in Salt-Sensitive Hypertension and Renal Damage

The Relationship Between Psychosocial Status and Hypertensive Condition

Obesity and Pulmonary Hypertension

The Mediterranean Diet: Lost in Translation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page